Cardiac Safety Evaluation of P03277
- Conditions
- Interventions
- First Posted Date
- 2018-09-05
- Last Posted Date
- 2022-07-18
- Lead Sponsor
- Guerbet
- Target Recruit Count
- 48
- Registration Number
- NCT03657264
- Locations
- 🇧🇪
Clinical Pharmacology unit, SGS-Life Science Service, Antwerpen, Belgium
Pharmacokinetics, Dialysability and Safety of P03277 in Healthy Volunteers and in Patients With Impaired Renal Function
- First Posted Date
- 2018-09-05
- Last Posted Date
- 2019-10-22
- Lead Sponsor
- Guerbet
- Target Recruit Count
- 40
- Registration Number
- NCT03657784
- Locations
- 🇲🇩
Republican Clinical Hospital, Arensia EM Unit, Chisinau, Moldova, Republic of
🇷🇴Arensia Phase I unit "Carol Davila" Nephrology Hospital, Bucharest, Romania
Pharmacokinetics, Pharmacodynamics Profile and Tolerance of P03277 in Healthy Subjects and Patients With Brain Lesions
- First Posted Date
- 2018-07-27
- Last Posted Date
- 2021-05-14
- Lead Sponsor
- Guerbet
- Target Recruit Count
- 142
- Registration Number
- NCT03603106
- Locations
- 🇧🇪
Clinical Pharmacology unit, SGS Life Science Services, Antwerpen, Belgium
Post-marketing Surveillance Study for Evaluation of Dotarem Safety
- First Posted Date
- 2017-02-09
- Last Posted Date
- 2017-05-02
- Lead Sponsor
- Guerbet
- Target Recruit Count
- 44456
- Registration Number
- NCT03048006
Post Marketing Surveillance Study for Evaluation of Efficacy and Safety of Dotarem in Magnetic Resonance Mammography
- First Posted Date
- 2017-02-02
- Last Posted Date
- 2017-05-02
- Lead Sponsor
- Guerbet
- Target Recruit Count
- 1537
- Registration Number
- NCT03041298
Proof of Concept Study Concerning Efficacy of P03277 MR Imaging in HCC Diagnosis
- Conditions
- Interventions
- First Posted Date
- 2016-11-25
- Last Posted Date
- 2021-10-26
- Lead Sponsor
- Guerbet
- Target Recruit Count
- 41
- Registration Number
- NCT02973516
- Locations
- 🇫🇷
CHU Angers, Angers, France
🇫🇷Hôpital Beaujon, Clichy, France
P03277 Dose Finding Study in Central Nervous System (CNS) Magnetic Resonance Imaging (MRI)
- Conditions
- Interventions
- First Posted Date
- 2015-12-17
- Last Posted Date
- 2021-10-25
- Lead Sponsor
- Guerbet
- Target Recruit Count
- 312
- Registration Number
- NCT02633501
- Locations
- 🇮🇹
Ospedali Riuniti di Ancona, Ancona, Italy
🇮🇹AO S. Andrea Universita La Sapienza, Roma, Italy
🇭🇺Pecsi Tudomany Egyetem Klinikai kozpont Idegsebeszeti Klinica, Pécs, Hungary
Evaluation of Lipiodol® Ultra Fluid in Association With Surgical Glues During Vascular Embolization.
- First Posted Date
- 2015-12-09
- Last Posted Date
- 2020-02-19
- Lead Sponsor
- Guerbet
- Target Recruit Count
- 125
- Registration Number
- NCT02625389
- Locations
- 🇮🇳
Division of Peripheral Vascular & Endovascular sciences, Medanta-The Medicity Hospital, Gurgaon, Haryana, India
🇮🇳Christian Medical College Hospital, Vellore, Tamil Nadu, India
DOTAREM Pharmacokinetics and Safety Study in Pediatric Subjects Aged < 2 Years
- First Posted Date
- 2015-04-08
- Last Posted Date
- 2017-03-09
- Lead Sponsor
- Guerbet
- Target Recruit Count
- 51
- Registration Number
- NCT02411201
- Locations
- 🇫🇷
CHU, Bordeaux, France
🇵🇱Uniwersytecki Szpital Dziecięcy w Lublinie, Lublin, Poland
🇫🇷Hôpital de Hautepierre, Strasbourg, France
Efficacy Evaluation of Dotarem®-Enhanced MRI Compared to Gadovist®/Gadavist®-Enhanced MRI in the Diagnosis of Brain Tumors
- First Posted Date
- 2014-01-13
- Last Posted Date
- 2016-12-30
- Lead Sponsor
- Guerbet
- Target Recruit Count
- 279
- Registration Number
- NCT02034708
- Locations
- 🇺🇸
UVM MRI Center for Biomedical Imaging, Burlington, Vermont, United States
🇺🇸University of Arizona Medical Center, Tucson, Arizona, United States
🇺🇸University of Washington Medical Center, Seattle, Washington, United States